Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.
Paterni I, Bertini S, Granchi C, Tuccinardi T, Macchia M, Martinelli A, Caligiuri I, Toffoli G, Rizzolio F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Minutolo F.
Paterni I, et al. Among authors: rizzolio f.
J Med Chem. 2015 Feb 12;58(3):1184-94. doi: 10.1021/jm501829f. Epub 2015 Jan 14.
J Med Chem. 2015.
PMID: 25559213
Free PMC article.